Latest filing published 30 Mar 2026 for INTENSITY THERAPEUTICS, INC., €199k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Lewis H. Bender: trading record in brief
Lewis H. Bender is a declared insider at 3 companies; the most frequent names are Interleukin Genetics Inc, Emisphere Technologies Inc and Intensity Therapeutics, Inc. Between 28 December 2006 and 26 March 2026, the trades on record add up to 14 filings.
Every open-market trade on record is a purchase: 11 purchases worth €19k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 2 share grants.
In size, the median ticket on the buying side is €2,118.
The latest filing, published on 30 March 2026, reports a share grant of €199k in Intensity Therapeutics, Inc. The most recent open-market purchase was published on 24 November 2008, 6,558 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Lewis H. Bender
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 37,749 shares@ US$6.11100.0% of flowCommon Stock, $0.0001 Par ValueSEC:0001238705-26-000005:0
- 110,000 shares@ US$0.27Common StockSEC:0001104659-09-018016:0
- 10,000 shares@ US$0.27Common StockSEC:0001104659-08-072759:0Canonical exit: 19 Feb 2009 (T+90)
- 100 shares@ US$0.24Common StockSEC:0001104659-08-072759:1Canonical exit: 22 Feb 2009 (T+90)
- 4,500 shares@ US$0.2499Common StockSEC:0001104659-08-072759:2Canonical exit: 22 Feb 2009 (T+90)
- 15,400 shares@ US$0.25Common StockSEC:0001104659-08-072759:3Canonical exit: 22 Feb 2009 (T+90)
- 100 shares@ US$0.41Common StockSEC:0001104659-08-072163:0Canonical exit: 16 Feb 2009 (T+90)
- 8,200 shares@ US$0.42Common StockSEC:0001104659-08-072163:1Canonical exit: 16 Feb 2009 (T+90)
- 10,000 shares@ US$0.498Common StockSEC:0001104659-08-072163:2Canonical exit: 16 Feb 2009 (T+90)
- 8,235 shares@ US$0.32Common StockSEC:0001104659-08-072163:3Canonical exit: 18 Feb 2009 (T+90)
- 1,765 shares@ US$0.33Common StockSEC:0001104659-08-072163:4Canonical exit: 18 Feb 2009 (T+90)
- 1,700 shares@ US$0.35Common StockSEC:0001104659-08-072163:5Canonical exit: 18 Feb 2009 (T+90)
- 3,000 shares@ US$1.40Common StockSEC:0001104659-08-011801:0Canonical exit: 19 May 2008 (T+90)
- 668 shares0Common StockSEC:0001230295-07-000064:0
14 of 14 declarations
